Smith, Katherine C. http://orcid.org/0000-0003-2140-1690
White, Sharon
DeSanto, Jennifer
Hannum, Susan
Mayonado, Nancy
Ahuja, Nita
Bowie, Janice
Cowall, David
Mischtschuk, Joan
Peairs, Kimberly
Thorner, Elissa
Tran, Phuoc
Wolff, Antonio
Snyder, Claire
Funding for this research was provided by:
Patient-Centered Outcomes Research Institute (IHS-1409-22534)
Article History
Received: 20 April 2021
Accepted: 5 June 2021
First Online: 22 July 2021
Declarations
:
: This study was reviewed and approved by the Johns Hopkins School of Medicine IRB (#110605).
: All data are from individuals who provided written consent to participate.
: N/A
: Dr. Nita Ahuja has licensed methylation biomarkers to Cepheid (PATENT # 10167513) and is a member of the Van Andel Institute-Stand Up To Cancer Research Dream Team. Dr. Ahuja is a member of the Scientific Advisory Council to the No Stomach for Cancer Foundation and the Yale New Haven Hospital Board of Trustees.Dr. Kimberly S. Peairs received research grant support from the Merck Foundation.Dr. Claire Snyder currently receives research support through the institution from Pfizer and Genentech and previously received royalties from UptoDate for section authorship related to survivorship.Dr. Phuoc T. Tran reports grants from Astellas Pharm, Bayer Healthcare, and RefleXion Medical; and advisory board/consulting for Noxopharm, Janssen- Taris Biomedical, AstraZeneca, and Myovant outside the submitted work. In addition, Dr. Tran has a patent 9114158—Compounds and Methods of Use in Ablative Radiotherapy licensed to Natsar Pharm.The remaining authors declare that they have no conflict of interests.
: The statements in this publication are solely the responsibility of the authors and do not necessarily represent the views of PCORI, its Board of Governors, or the Methodology Committee.